JPMorgan Chase & Co’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-250
| Closed | – | – | 6145 |
|
|
2022
Q2 | $0 | Buy |
250
+199
| +390% | – | ﹤0.01% | 6210 |
|
|
2022
Q1 | $0 | Sell |
51
-8,782
| -99% | – | ﹤0.01% | 6198 |
|
|
2021
Q4 | $49K | Buy |
8,833
+8,684
| +5,828% | +$48.2K | ﹤0.01% | 5086 |
|
|
2021
Q3 | $1K | Sell |
149
-636
| -81% | -$4.27K | ﹤0.01% | 5486 |
|
|
2021
Q2 | $13K | Sell |
785
-9,066
| -92% | -$150K | ﹤0.01% | 5190 |
|
|
2021
Q1 | $259K | Sell |
9,851
-4,270
| -30% | -$112K | ﹤0.01% | 4358 |
|
|
2020
Q4 | $510K | Buy |
14,121
+11,945
| +549% | +$431K | ﹤0.01% | 3735 |
|
|
2020
Q3 | $78K | Buy |
2,176
+621
| +40% | +$22.3K | ﹤0.01% | 4164 |
|
|
2020
Q2 | $66K | Buy |
1,555
+1,253
| +415% | +$53.2K | ﹤0.01% | 4115 |
|
|
2020
Q1 | $24K | Sell |
302
-7
| -2% | -$556 | ﹤0.01% | 4316 |
|
|
2019
Q4 | $29K | Hold |
309
| – | – | ﹤0.01% | 4372 |
|
|
2019
Q3 | $23K | Sell |
309
-1,337
| -81% | -$99.5K | ﹤0.01% | 4458 |
|
|
2019
Q2 | $163K | Buy |
+1,646
| New | +$163K | ﹤0.01% | 3840 |
|